Oxford Medical Dx, V&F Analyse Ink Mass Spec Alliance | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oxford Medical Diagnostics and V&F Analyse- und Messtechnik announced Monday that they have formed an alliance based on mass spectrometry technology.

Unde the terms of the alliance, Oxford, UK-based OMD will offer and support V&F's high-performance mass spec analyzers in the UK and Ireland. In addition, OMD will establish a contract batch sample analysis service at its Oxford labs to provide analytical services to customers using V&F's instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.